Biomechanical and Metabolic Assessment Pre and Post Vertebroplasty in Multiple Myeloma Patients With Vertebral Collapse
NCT ID: NCT06255639
Last Updated: 2024-02-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
20 participants
OBSERVATIONAL
2020-10-15
2024-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
MOVEMENT ANALYSIS IN PATIENTS UNDERGOING VERTEBRECTOMIES FOR SPINE ONCOLOGY: A PILOT STUDY
NCT07326969
Bone-biomarkers of Spinal Cord Injury Patients
NCT04403256
Bone Strength After Spinal Cord Injury
NCT01853488
Incomplete Cervical SCI Without Instability
NCT05653206
Treatment for Chronic Spinal Cord Injury: Surgery With Rehabilitation vs Rehabilitation
NCT02663310
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MM patient candidate to vertebroplasty
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of multiple myeloma;
* Clinical indication and eligibility for vertebroplasty procedure;
* Performance Status (ECOG) 0-2;
* Life expectancy greater than three months;
* Low-resolution full skeletal CT scan at disease onset and/or at follow-up;
* Spine pain with stiffness and functional impediment pre vertebroplasty;
* Able to express appropriate consent for participation in the study (e.g. Able to understand Italian, patient with intact cognitive abilities)
Exclusion Criteria
* unstable spinal injuries, requiring an orthopaedic back brace;
* risk of spinal cord injury;
* body mass index BMI\>28 kg/m2.
* absence of signed informed consent form
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centro di Riferimento Oncologico - Aviano
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mariagrazia Michieli, MD
Role: PRINCIPAL_INVESTIGATOR
Centro di Riferimento Oncologico (CRO) di Aviano - IRCCS
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centro di Riferimento Oncologico (CRO) di Aviano - IRCCS
Aviano, Pordenone, Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CRO-2020-35
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.